® Publicaciones Científicas


Antitumor effect of a novel proapoptotic peptide that impairs the phospholylation by the protein kinase 2 (casein kinase 2). S.E. Perea, O. Reyes, Y. Puchades, O. Mendoza, N. Santiago, I. Torrens, A. Santos, R. Silva, B. Acevedo, E. Lopez, V. Falcon, D.F. Alonso. Cancer Research 64: 7127-7129, 2004.

Potential application of desmopressin as a perioperative adjuvant in cancer surgery. Biological effects, antitumor properties and clinical usefulness.  D.E. Gomez, G.V. Ripoll, S. Giron, D.F. Alonso. Cancer Therapy 2: 279-290, 2004.

Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice. M. Yamazaki, T. Akahane, T. Buck, H. Yoshiji, D.E. Gomez, D.J. Schoeffner, E. Okajima, S.R. Harris, O.R. Bunce, S.S. Thorgeirsson, Thorgeirsson UP. Carcinogenesis 25: 1735-1746, 2004.

7A7 MAb: A new tool for the preclinical evaluation of EGFr-based therapies. G. Garrido, B. Sanchez, H.M. Rodriguez, P. Lorenzano Menna, D.F. Alonso, L.E. Fernandez. Hybridoma and Hybridomics 23: 168-175, 2004.

Role of protein kinase C-dependent signaling pathways in the antiangiogenic properties of nafoxidine. M.S. De Lorenzo, H.G. Farina, D.F. Alonso, D.E. Gomez. Anticancer Research 24: 1737-1743, 2004.